SESelçuk Erkılınç

Selçuk Erkılınç

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Selçuk Erkılınç has a total of 106 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Association between preoperative primary tumor SUVmax on FDG PET-CT and high-risk pathological features for the prediction of lymph node metastases in endometrial cancer

    by Serhan Can İsCan, Çağlayan Biçer, Fatih Akkuş, Selçuk Erkılınç

    Aim:To evaluate the association between preoperative primary tumor SUVmax on 18F-FDG PET-CT and lymph node metastasis, and to assess its relationship with high-risk pathological features in surgically staged endometrial cancer patients.Materials and Methods: In this retrospective cohort study, 134 patients with histologically confirmed endometrial cancer who underwent preoperative 18F-FDG PET-CT and primary surgical staging were included. Primary tumor SUVmax, clinical, imaging, and histopathological parameters were compared between patients with and without lymph node metastasis. ROC curve analysis and univariable/multivariable logistic regression were performed to identify predictors of nodal metastasis.Results:Lymph node metastasis was present in 16 patients (11.9%). Median SUVmax was significantly higher in the lymph-node-positive group (22.60 vs. 14.56; p = 0.003). SUVmax showed moderate discrimination for lymph node metastasis (AUC 0.733; optimal cutoff ≥21.10; sensitivity 62.5%, specificity 79.7%, negative predictive value 94.0%). Pathological tumor diameter showed the numerically highest AUC (0.822), though DeLong's test revealed no significant pairwise differences among ROC curves. On univariable analysis, SUVmax, tumor diameter, CA125, high grade, non-endometrioid histology, LVSI, deep myometrial invasion, and cervical involvement were significantly associated with nodal metastasis. In the exploratory multivariable model, LVSI remained independently associated (adjusted OR 14.33; p = 0.001), while SUVmax (p = 0.182) and deep myometrial invasion (p = 0.094) lost statistical significance.Conclusion: Primary tumor SUVmax is significantly associated with lymph node metastasis and correlates with high-risk pathological features in endometrial cancer, with a high negative predictive value supporting its role in preoperative risk stratification. While LVSI appeared as the most significant predictor overall, it can only be determined after surgery; in contrast, SUVmax, which is accessible preoperatively, could function as a therapeutically relevant proxy for recognizing high-risk individuals prior to the operation. Larger prospective research is required for confirmation.

  • The Erkilinc Technique for vNOTES Hysterectomy: A Speculum-assisted Approach Without Prior Vaginal Dissection: A 163-Case Series

    by Selçuk Erkılınç, Serhan Can İşCan, Sena Özcan, Ufuk Atlıhan, Çağlayan Biçer, Betül Öztürk, Can Ata, İlKer Çakır

  • Open Access

    Diagnostic role of galanin in distinguishing endometrial atypical hyperplasia and carcinoma from benign endometrial conditions

    by Can Ata, Tevfik Berk Bildaci, Ufuk Atlihan, Huseyin Aytug Avsar, Selcuk Erkilinc

    Endometrial atypical hyperplasia is recognized as a precursor to endometrial cancer, which ranks as the fourth most common cancer in women and is the leading type of gynecological malignancy in high-income countries. The development and progression of endometrial cancer are strongly linked to increased body fat and insulin resistance. Peptides involved in glucose metabolism, such as leptin, chemerin, and galanin, may contribute to carcinogenesis through shared pathways. This study aims to investigate the role of galanin levels in diagnosing endometrial neoplastic disorders. This prospective case-control study included 85 patients, divided into three groups: endometrial cancer, atypical hyperplasia, and a control group. Serum galanin levels were measured using ELISA across all groups. The mean galanin levels were 472.76 ± 44.86 pg/ml in Control Group, 516.81 ± 51.15 pg/ml in EAH, and 543.15 ± 73.22 pg/ml in Cancer Group. Galanin levels were found to be significantly different among groups. (p < .001) . Galanin levels have the potential to differentiate between normal endometrium and patients with endometrial hyperplasia.


  • Evaluating the Impact of Dienogest on Quality of Life in Turkish Patients with Endometriosis: A Clinical Study

    by Tevfik Berk Bıldacı, Yasemin Ozgunayer Atmaca, Can Ata, Ufuk Atlıhan, Hüseyin Aytuğ Avşar, Selçuk Erkılınç

    Purpose This study aimed to evaluate the effectiveness of dienogest in alleviating the negative effects associated with endometriosis in Turkish patients. The impact of the treatment on health-related quality of life (HRQoL) was assessed using the validated Turkish version of the Endometriosis Health Profile-30 (EHP-30) questionnaire. Methods A total of 119 patients with a confirmed diagnosis of endometrioma characterized by a unilocular cyst with homogeneous ground-glass echogenicity were included in this study, conducted at a tertiary care center. All participants were prescribed or already have been prescribed a continuous regimen of 2 mg/day dienogest for symptom control. Each patient completed the core section of the EHP-30 questionnaire twice: before treatment initiation and after a defined treatment period. Results A significant improvement was observed in total EHP-30 scores (from 96.92 to 52.03, p < .001). Notable improvements were also found in the pain (p < .001), self-image (p < .001), and emotional well-being (p < .001) subdomains. Changes in EHP-30 scores were not found to be significantly correlated with treatment duration, reduction in endometrioma size, or changes in CA125 levels. Conclusion Dienogest significantly improves quality of life even with short-term use and stands out as an effective treatment option for endometriosis.

  • Systemic Immune-Inflammation Index and Other Inflammation Biomarkers in the Diagnosis of Gestational Diabetes Mellitus

    by Tevfik Berk Bıldacı, Can Ata, Merve Nur Cakmak, Hüseyin Aytuğ Avşar, Ufuk Atlıhan, Selçuk Erkılınç

    Aims: Gestational diabetes mellitus (GDM) emerges during pregnancy due to physiological shifts, resulting in an adverse intrauterine environment characterized by insulin resistance and hyperglycemia, with inflammation believed to play a significant role. While inflammation typically protects the body, it can also have adverse effects. Neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), systemic immune-inflammation index (SII), and lymphocyte-to-monocyte ratio (LMR) are recognized as biomarkers of inflammation. Methods: This retrospective cohort study took place between January 2022 and December 2023 at a tertiary training and research hospital. A total of 567 patients were included in the study. A comparison of inflammation markers was conducted between patients with and without GDM. Results: A significant difference was observed in the mean SII values between the groups, with group A (Control group) exhibiting 1144 ± 400 and group B (Patients with GDM) showing 1280 ± 496 (p = .002). Another significant difference observed between groups for NLR (p= .001). Conclusion: The significant differences observed in SII values between patient groups, coupled with the discriminative abilities of SII and NLR in diagnosing GDM, underscore the potential clinical relevance of these markers.

  • Endometriozis riskini değerlendirmede trigliserid-glikoz indeksinin öngörücü rolü

    by Ufuk Atlıhan, Ferruh Acet, Onur Yavuz, Tevfik Berk Bıldacı, Selçuk Erkılınç, Can Ata, Ali Özay, Hüseyin Aytuğ Avşar, Alper İlEri, Adnan Budak

    Amaç: Çalışmamızın amacı endometriozis riskini değerlendirmede trigliserid-glikoz indeksinin öngörücü rolünü değerlendirmektir. Gereç ve yöntemler: Çalışmamıza Şubat 2018-2024 tarihleri arasında kadın doğum kliniğimize başvuran ve endometriozis tanısı konulan 91 hasta ve kontrol grubundaki 260 hasta dahil edildi. Tüm hastaların vücut kitle indeksi, toplam kolesterol, trigliserid, yüksek yoğunluklu lipoprotein kolesterol, düşük yoğunluklu lipoprotein kolesterol, trigliserid-glikoz indeksi, luteinize edici hormon, folikül uyarıcı hormon , açlık kan şekeri düzeyleri hastane veri tabanında retrospektif olarak değerlendirildi. Bulgular: Endometriozis grubunda oral kontraseptif kullanım oranı ve sigara içme oranı, kontrol grubuna göre anlamlı yüksek saptandı (p

  • Open Access

    The relationship of antimullerian hormone with severity of clinical symptoms in polycystic ovary syndrome

    by Can Ata, Ufuk Atlihan, Huseyin Aytug Avsar, Onur Yavuz, Selcuk Erkilinc, Tevfik Berk Bildaci

    Polycystic ovary syndrome (PCOS) is an endocrine disorder prevalent in around 6–8% of women in their reproductive years. The measurement of Anti-Müllerian Hormone (AMH) holds particular promise in discerning both the diagnosis and the extent of severity in PCOS cases. This study aims to evaluate the effectiveness of using AMH as a potential tool for identifying and diagnosing the severity of clinical aspects associated with the syndrome. A retrospective analysis was performed on 309 female patients who presented for consultation at our hospital’s gynecology outpatient clinic and were diagnosed with PCOS based on the Rotterdam criteria, between January 2018 and March 2022. Data were extracted from the hospital database and systematically assessed. Patients were divided into two groups based on the mean AMH level of 7.5 ng/mL, allowing comparison between higher and lower AMH subgroups. Clinical symptoms and findings were assessed based on AMH values. A statistically significant difference was observed between groups for the mean levels of total testosterone, androstenedione, free androgen index, luteinizing hormone, and follicle-stimulating hormone (p < 0.05). Additionally, a statistically significant difference was noted between AMH groups and the presence of oligomenorrhea (p < 0.05). Even at the higher end of the spectrum, AMH retains significant value in determining the clinical aspects of PCOS.


  • Role of hematologic parameters in predicting early pregnancy loss

    by Can Ata, Ufuk Atlıhan, Onur Yavuz, Alper İlEri, Hüseyin Aytuğ Avşar, Mehmet Emre Peker, Tevfik Berk Bıldacı, Selçuk Erkılınç

    Aim: To investigate the role of hematologic parameters in predicting early pregnancy loss (EPL). Materials and Methods: Two hundred eighty-four pregnant women aged between 18 and 45 years who were admitted to our hospital between January 2021-2024 and whose gestational sac measurements were in the 6th-7th weeks, were included in the study. One hundred thirty-three pregnant women who experienced EPL were included in the study group, and the control group consisted of 151 healthy pregnant women who gave birth at ≥37 weeks. Pregnant women who experienced EPL and those who give birth at ≥37 weeks were compared. Age, body mass index (BMI), gravida, parity, abortion, smoking status, and hematologic parameters of all patients were evaluated retrospectively. Results: SII was significantly higher in the EPL group compared with the control group (p=0.044). SIRI was significantly higher in the EPL group compared with the control group (p=0.042). PIV was significantly higher in the EPL group compared with the control group (p=0.048). No significant difference was found in terms of NLR, PLR, MLR, and MPV between the groups. Conclusion: Hematologic parameters such as SII, SIRI, and PIV provide valuable information about inflammatory processes associated with early pregnancy loss. Integration of these parameters into routine prenatal screening protocols may improve the early detection and management of pregnancies at risk of loss. Further studies are needed to determine standard threshold values.

  • Open Access

    Retrospective evaluation of patients who underwent myomectomy during cesarean section

    by Hüseyin Aytuğ Avşar, Onur Yavuz, Can Ata, Tevfik Berk Bıldacı, Selçuk Erkılınç

    Aim: The aim of our study was to evaluate the obstetric and neonatal outcomes of patients who underwent myomectomy at the time of cesarean section (C/S). Materials and Methods: A total of 480 patients aged 19-45 who presented to the gynecology and obstetrics clinic between 2018-2023, underwent pregnancy follow-up and C/S delivery in our hospital, and met the inclusion criteria were included in our study. Myomectomy was performed during C/S in 220 patients included in the study, and it was not performed in 260 patients. Age, number of pregnancies, abortion status, fetal weight at birth, Apgar scores, C/S indication, myoma localization, and hemoglobin values of all patients were compared retrospectively. Results: The number of abortions was significantly higher in the myomectomy (+) group (p

  • Open Access

    The role of biochemical markers in predicting pre-eclampsia

    by Ufuk Atlıhan, Begüm Ertan, Mehmet Emre Peker, Can Ata, Onur Yavuz, Hüseyin Aytuğ Avşar, Alper İlEri, Tevfik Berk Bıldacı, Selçuk Erkılınç

    Aim: The aim of our study was to evaluate the role of biochemical markers in predicting preeclampsia. Materials and Methods: 7240 women whose pregnancy follow-ups and deliveries were carried out by us between March 2018 and March 2024 were retrospectively screened. Patients in the study group consisted of 102 women diagnosed with preeclampsia at <34 weeks of gestation, and patients in the control group consisted of 118 women who gave birth at ≥37 weeks of gestation. Demographic characteristics and obstetric and biochemical outcomes of the two groups were compared with each other. Results: The body mass index (BMI) value was significantly higher in the preeclampsia group compared with the controls group (p=0.016). The birth weight value was significantly lower in the preeclampsia group compared with the controls group (p<0.001). The gestational week at delivery was significantly lower in the preeclampsia group compared with the controls group (p<0.001). Lymphocyte and platelet counts were significantly lower in the preeclampsia group compared with the controls group (p<0.001 and p<0.001, respectively). NLR and SII value were significantly higher in the preeclampsia group compared with the controls group (p=0.022, p<0.001, respectively). Conclusion: Our study reveals important clinical and laboratory differences in preeclamptic pregnancies. Increased inflammatory markers were found to be a feature of preeclamptic pregnancies and are consistent with the existing literature. Our findings can be used to determine early diagnosis and comprehensive management strategies to minimize the risks associated with preeclampsia.